LUV:NYSESouthwest Airlines Company Analysis
Data as of 2026-04-16 - not real-time
$41.70
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Southwest Airlines is trading at $41.7, which sits below the DCF‑derived fair value of $43.39, implying roughly a 6% upside potential. The stock’s trailing P/E of 52.8 is well above the airline industry average of 30.9, suggesting current earnings appear stretched, yet the forward P/E of 9.2 points to strong earnings growth expectations. A beta of 1.42 and a 30‑day volatility of 54% highlight a higher‑than‑average market risk profile, while the RSI of 53 and a bullish MACD histogram indicate neutral‑to‑slightly‑positive momentum. Dividend yield stands at 1.75% with a payout ratio of 91%, raising questions about dividend sustainability given negative free cash flow. Recent leadership announcements aim to enhance customer experience, and UBS maintained a Buy rating with a revised price target of $56, while Redburn raised its target to $35 despite a sell rating. Analyst consensus remains a “hold,” and the median price target of $45 aligns with the modest upside suggested by the valuation model.
The technical landscape shows the price hovering between a support of $35.73 and resistance of $43.43, with decreasing volume that may limit short‑term rally strength. The company’s revenue growth of 7.4% and a forward EPS of $4.51 reinforce a medium‑term earnings upside narrative. However, a debt‑to‑equity ratio of 74.9% and negative free cash flow underscore liquidity concerns that temper long‑term optimism. Overall, the stock presents a blend of value and growth attributes, with modest upside, elevated risk, and dividend sustainability issues.
The technical landscape shows the price hovering between a support of $35.73 and resistance of $43.43, with decreasing volume that may limit short‑term rally strength. The company’s revenue growth of 7.4% and a forward EPS of $4.51 reinforce a medium‑term earnings upside narrative. However, a debt‑to‑equity ratio of 74.9% and negative free cash flow underscore liquidity concerns that temper long‑term optimism. Overall, the stock presents a blend of value and growth attributes, with modest upside, elevated risk, and dividend sustainability issues.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with limited upside
- High volatility and beta increase short‑term risk
- Decreasing volume may constrain price moves
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward earnings growth implied by low forward P/E
- DCF fair value indicates modest upside
- Analyst upgrades and price‑target revisions supporting upside
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong brand and loyalty program underpin demand recovery
- Elevated debt levels and negative free cash flow limit margin expansion
- Dividend yield attractive but sustainability concerns remain
Key Metrics & Analysis
Financial Health
Revenue Growth7.40%
Profit Margin1.57%
P/E Ratio52.8
ROE4.81%
ROA0.95%
Debt/Equity74.94
P/B Ratio2.7
Op. Cash Flow$1.8B
Free Cash Flow$-683875008
Industry P/E30.9
Technical Analysis
TrendNeutral
RSI53.8
Support$35.73
Resistance$43.43
MA 20$39.30
MA 50$44.75
MA 200$37.55
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98
Valuation
Fair Value$43.39
Target Price$44.21
Upside/Downside6.02%
GradeFair
TypeBlend
Dividend Yield1.75%
Risk Assessment
Beta1.42
Volatility54.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.